Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution
JCO Precision Oncology · 2026-06 · 10 (6)
DOI: 10.1200/po-26-00385 ↗Kurz gefasst
Leserbrief in der Zeitschrift JCO Precision Oncology, 2026-06. Verfasst von Richard Houlston und 4 weiteren Autor:innen. Beteiligte Einrichtung: Richard Houlston, MD, PhD, Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom, Paul Pharoah, MD, PhD, De…. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Richard Houlston, MD, PhD, Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, United Kingdom, Paul Pharoah, MD, PhD, Department of Computational Biomedicine, Cedars-Sinai Medical Center, Lo…
ORCID-Profile: Richard Houlston, Richard Sullivan, Clare Turnbull, Amit Sud
Zitieren
APA
Houlston, R., Pharoah, P., Sullivan, R., Turnbull, C., & Sud, A. (2026). Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution. JCO Precision Oncology, 10(6). https://doi.org/10.1200/po-26-00385
Vancouver
Houlston R, Pharoah P, Sullivan R, Turnbull C, Sud A. Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution. JCO Precision Oncology. 2026;10(6). doi:10.1200/po-26-00385
BibTeX
@article{Houlston2026,
author = {Houlston, Richard and Pharoah, Paul and Sullivan, Richard and Turnbull, Clare and Sud, Amit},
title = {Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {6},
doi = {10.1200/po-26-00385}
}
EUVIMED